NCT05081011

Managing Insulin With a Voice AI

Using an AI-based Voice Assistant to Manage Insulin in Diabetes: a Randomized-Control Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 39 (actual)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study randomizes participants to have their basal insulin titrated either through standard of care or by receiving prompts through interactions with an AI-enabled smart speaker device. The primary objective of this study is to investigate the feasibility of an AI-enabled smart speaker device and whether such a device facilitates insulin titration management, increases insulin adherence and decreases time to optimal insulin dose. The secondary objective of the study is to explore whether the device improves glycemic control as defined by improvements in fasting blood sugar.

Conditions

• Medication Adherence

Interventions

Type	Name	Description
DEVICE	Voice Assistant Device	Voice AI-enabled smart speaker device delivers daily custom insulin titration instructions.
DEVICE	Voice Assistant Device	Voice AI-enabled smart speaker device delivers daily generic insulin reminders.

Timeline

• Start date: 2021-03-24
• Primary completion: 2022-12-01
• Completion: 2022-12-01
• First posted: 2021-10-18
• Last updated: 2024-01-02
• Results posted: 2024-01-02

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study